LCTX logo
Lineage Cell Therapeutics, Inc.(LCTX)
Last print unknown agoAbout this dataData status
$0.95▼-0.03 (-2.61%)Stale · unknown old

LCTX Financing Cash Flow

$32.24MTTM · USD

Period ending:

LCTX FY Cash from FinancingUSD
LCTX FY Cash from Financing1992-06-30: $5.30M1993-06-30: -$100.00K1994-06-30: $3.90M1995-06-30: -$200.00K1996-06-30: $1.10M1998-06-30: $6.70M1998-12-31: $400.00K1999-12-31: $7.42M2000-12-31: $915.96K2001-12-31: $3.55M2002-12-31: $1.76M2003-12-31: $86.90K2004-12-31: $2.19M2005-12-31: $1.88M2006-12-31: $126.002007-12-31: $694.94K2008-12-31: $2.52M2009-12-31: $16.48M2010-12-31: $25.77M2011-12-31: $3.86M2012-12-31: $1.91M2013-12-31: $34.26M2014-12-31: $63.62M2015-12-31: $64.78M2016-12-31: $32.78M2017-12-31: $55.39M2018-12-31: $5.77M2019-12-31: $617.00K2020-12-31: $29.87M2021-12-31: $36.93M2022-12-31: $1.63M2023-12-31: $6.42M2024-12-31: $35.86M2025-12-31: $26.95M$64.78M-$200.00K
1992-06-302025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

LCTX financing cash flow history

Cash from issuing/repaying debt and equity. The available annual fiscal periods series contains 34 observations from Jun 30, 1992 to Dec 31, 2025.

Lineage Cell Therapeutics, Inc. Common Stock Financing Cash Flow — Annual fiscal periods (USD)
Period endingFinancing Cash Flow (USD)
26,950,000
35,857,000
6,423,000
1,632,000
36,930,000
29,865,000
617,000
5,774,000
55,391,000
32,782,000
64,775,000
63,623,243
34,263,608
1,913,378
3,862,414
25,767,456
16,482,966
2,516,895
694,937
126
1,877,160
2,190,274
86,896
1,764,670
3,549,360
915,964
7,420,412
400,000
6,700,000
1,100,000
-200,000
3,900,000
-100,000
5,300,000

Compare financing cash flow

All LCTX financial metrics · LCTX stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.